search results for

refine results

sort by


result type


Press Releases

98 percent of Hack Reactor students land jobs

When it comes to landing a job in tech, coding camps promise to get you there faster. CNBC's Aditi Roy reports. Suzy Welch, LinkedIn contributing editor, weighs in.


The 1% market

Margie Patel, Wells Fargo Funds, and Craig Hodges, Hodges Capital, discuss the current state of the markets, including their take on Mylan and the biotech sector. CNBC's Meg Tirrell also reports that senators are asking Mylan for more information on EpiPen pricing.


Clinton: EpiPen price hikes by Mylan 'outrageous'

Hillary Clinton makes a statement on Mylan's EpiPen price hike. CNBC's Meg Tirrell reports.


Pitts on EpiPen outrage: 'Perfect storm of stupidity'

Peter Pitts, former FDA associate commissioner and Center for Medicine in the Public Interest president, discusses FDA's role in the Mylan EpiPen outrage.


EpiPen outrage: Increased political attention

CNBC's Meg Tirrell reports the latest on Mylan and the EpiPen pricing outrage. Suzy Welch, LinkedIn contributing editor, weighs in.


Trump flip-flopping on immigration?

Jacob Monty, Houston-based immigration attorney and GOP activist, shares his take on Donald Trump's change of tone on immigration.


One Miami doctor's fight against Zika

Having treated over a dozen cases already, Dr. Christine Curry, University of Miami, describes what it is like to treat pregnant women with Zika.


Good, bad, ugly: ISIL, MRO & PRTS

CNBC's Michelle Caruso-Cabrera looks at good, bad and ugly stocks, including Intersil Corp, Marathon Oil and U.S. Auto Parts Network.


'Biggest bond bubble' ever?

We are in the biggest bond bubble in world history according to Paul Singer's hedge fund Elliot Management. CNBC's Kate Kelly reports. Rick Rieder, BlackRock CIO of Global Fixed Income, weighs in.


'Adventure Capitalists' premieres Monday on CNBC

Craig Cooper, host of CNBC's "Adventure Capitalists," discusses the show's premiere on Monday, and the nature of entrepreneurship.